Genetic Immunity, Inc. is a leading therapeutic vaccine company specializing in the development of immune therapy products for a number of infectious diseases, including HIV, cancer, allergy, viruses and more. Our lead product candidate, Dermavir, is a Phase III clinical stage immune therapy for the treatment of HIV..